Picture EBD Group World of Partnering Opportunities 650x100px
Document › Details

Recipharm AB. (5/9/18). "Press Release: Recipharm Appoints New Chief Financial Officer".

Organisations Organisation Recipharm AB
  Group Recipharm (Group)
  Organisation 2 Accenture (Group)
Products Product drug development services
  Product 2 contract manufacturing (drugs)
Persons Person Hägglöv, Tobias (Recipharm 201805– CFO announced to join later in 2018 before LEAX + Electolux + SAS + Accenture)
  Person 2 Eldered, Thomas (Flerie Invest 2010– Founder + Recipharm 201106 CEO + Co-Founder)

Recipharm AB (publ) today announced the appointment of Tobias Hägglöv as Recipharm’s new Chief Financial Officer, effective later in the year. Tobias will be a member of Recipharm Group Management team.

Tobias Hägglöv has comprehensive experience from finance positions, serving previously at Electrolux, SAS and Accenture. He joins Recipharm from a position as the CFO at LEAX. Tobias holds a degree in Finance and Business Administration from the University of Stockholm, and a M.Sc. from Royal Institute of Technology, Stockholm, Sweden.

Contact information

Thomas Eldered, CEO, telephone: +46 8 602 52 10

This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 9 May 2018, at 10:00 am CET.

About Recipharm

Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 5,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 5.3 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.

For more information on Recipharm and our services, please visit

Record changed: 2023-06-05


Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Recipharm (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top